449 related articles for article (PubMed ID: 23392438)
21. Lung cancer in patients with chronic obstructive pulmonary disease-- incidence and predicting factors.
de Torres JP; Marín JM; Casanova C; Cote C; Carrizo S; Cordoba-Lanus E; Baz-Dávila R; Zulueta JJ; Aguirre-Jaime A; Saetta M; Cosio MG; Celli BR
Am J Respir Crit Care Med; 2011 Oct; 184(8):913-9. PubMed ID: 21799072
[TBL] [Abstract][Full Text] [Related]
22. Bronchiectasis in COPD patients: more than a comorbidity?
Martinez-Garcia MA; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1401-1411. PubMed ID: 28546748
[TBL] [Abstract][Full Text] [Related]
23. Emphysema and bronchiectasis in COPD patients with previous pulmonary tuberculosis: computed tomography features and clinical implications.
Jin J; Li S; Yu W; Liu X; Sun Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():375-384. PubMed ID: 29416328
[TBL] [Abstract][Full Text] [Related]
24. Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease.
Maekura R; Hiraga T; Miki K; Kitada S; Miki M; Yoshimura K; Yamamoto H; Kawabe T; Mori M
Int J Chron Obstruct Pulmon Dis; 2015; 10():1787-800. PubMed ID: 26366071
[TBL] [Abstract][Full Text] [Related]
25. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
[TBL] [Abstract][Full Text] [Related]
26. Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.
Gallego M; Pomares X; Espasa M; Castañer E; Solé M; Suárez D; Monsó E; Montón C
BMC Pulm Med; 2014 Jun; 14():103. PubMed ID: 24964956
[TBL] [Abstract][Full Text] [Related]
27. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
28. Does bronchiectasis affect COPD comorbidities?
Nowiński A; Korzybski D; Bednarek M; Goljan-Geremek A; Puścińska E; Śliwiński P
Adv Respir Med; 2019; 87(6):214-220. PubMed ID: 31970723
[TBL] [Abstract][Full Text] [Related]
29. Preoperative spirometry results as a determinant for long-term mortality after EVAR for AAA.
Ohrlander T; Dencker M; Acosta S
Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):43-7. PubMed ID: 22051733
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of bronchiectasis in emphysema-predominant COPD patients.
Dou S; Zheng C; Cui L; Xie M; Wang W; Tian H; Li K; Liu K; Tian X; Wang X; Zhang Q; Ai X; Che J; Liu Q; Li H; Xiao W
Int J Chron Obstruct Pulmon Dis; 2018; 13():2041-2047. PubMed ID: 29988718
[TBL] [Abstract][Full Text] [Related]
31. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.
Almagro P; Salvadó M; Garcia-Vidal C; Rodríguez-Carballeira M; Cuchi E; Torres J; Heredia JL
Respiration; 2012; 84(1):36-43. PubMed ID: 21996555
[TBL] [Abstract][Full Text] [Related]
32. The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis. A Cluster Analysis Approach.
Martínez-García MÁ; Vendrell M; Girón R; Máiz-Carro L; de la Rosa Carrillo D; de Gracia J; Olveira C
Ann Am Thorac Soc; 2016 Sep; 13(9):1468-75. PubMed ID: 27348199
[TBL] [Abstract][Full Text] [Related]
33. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
[TBL] [Abstract][Full Text] [Related]
34. Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE.
de Torres JP; Casanova C; Marín JM; Pinto-Plata V; Divo M; Zulueta JJ; Berto J; Zagaceta J; Sanchez-Salcedo P; Cabrera C; Carrizo S; Cote C; Celli BR
Thorax; 2014 Sep; 69(9):799-804. PubMed ID: 24969641
[TBL] [Abstract][Full Text] [Related]
35. The effect of airflow limitation on the cause of death in patients with COPD.
Alfageme I; Reyes N; Merino M; Reina A; Gallego J; Lima J; Palacios Z
Chron Respir Dis; 2010 Aug; 7(3):135-45. PubMed ID: 20688891
[TBL] [Abstract][Full Text] [Related]
36. Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis.
Lee AL; Button BM; Denehy L; Roberts SJ; Bamford TL; Ellis SJ; Mu FT; Heine RG; Stirling RG; Wilson JW
Respirology; 2014 Feb; 19(2):211-217. PubMed ID: 24033416
[TBL] [Abstract][Full Text] [Related]
37. Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry.
De la Rosa D; Martínez-Garcia MA; Giron RM; Vendrell M; Olveira C; Borderias L; Maiz L; Torres A; Martinez-Moragon E; Rajas O; Casas F; Cordovilla R; de Gracia J
PLoS One; 2017; 12(5):e0177931. PubMed ID: 28542286
[TBL] [Abstract][Full Text] [Related]
38. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection.
Sekine Y; Suzuki H; Yamada Y; Koh E; Yoshino I
Thorac Cardiovasc Surg; 2013 Mar; 61(2):124-30. PubMed ID: 22535670
[TBL] [Abstract][Full Text] [Related]
39. Resting heart rate is a predictor of mortality in COPD.
Jensen MT; Marott JL; Lange P; Vestbo J; Schnohr P; Nielsen OW; Jensen JS; Jensen GB
Eur Respir J; 2013 Aug; 42(2):341-9. PubMed ID: 23143550
[TBL] [Abstract][Full Text] [Related]
40. Co-existence of COPD and bronchiectasis: a risk factor for a high ratio of main pulmonary artery to aorta diameter (PA:A) from computed tomography in COPD patients.
Dou S; Zheng C; Ji X; Wang W; Xie M; Cui L; Xiao W
Int J Chron Obstruct Pulmon Dis; 2018; 13():675-681. PubMed ID: 29520135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
